Cancer Clinical Investigation

Search results

• Tilray Beverages Announces Campaign to Raise Awareness for Men’s Health

  Kaplan, S. & Sfakianos, J.

  14/06/24

  1 item of Media coverage

  Press/Media

• Study Results from Icahn School of Medicine at Mount Sinai Broaden Understanding of Liver Cancer (Immunotherapy and Transplantation for Hepatocellular Carcinoma)

  Tabrizian, P. & Schwartz, M.

  14/06/24

  1 item of Media coverage

  Press/Media

• FLOT proves better than CROSS in oesophageal cancer

  Goodman, K.

  13/06/24

  1 item of Media coverage

  Press/Media

• Studies from Icahn School of Medicine at Mount Sinai Have Provided New Data on Robotics (Ai-powered Real-time Annotations During Urologic Surgery: the Future of Training and Quality Metrics)

  Badani, K. & Tewari, A.

  12/06/24

  1 item of Media coverage

  Press/Media

• Icahn School of Medicine at Mount Sinai Researchers Publish New Data on Epilepsy (Segmentation and quantification of venous structures and perivascular spaces in the thalamus in epilepsy using 7 Tesla MRI)

  Verma, G. & Balchandani, P.

  11/06/24

  1 item of Media coverage

  Press/Media

• Recent Studies from Icahn School of Medicine at Mount Sinai Add New Data to Graft-Versus-Host Disease (Flares of Acute Graft-versus-host Disease: a Mount Sinai Acute Gvhd International Consortium Analysis)

  Levine, J. & Akahoshi, Y.

  10/06/24

  1 item of Media coverage

  Press/Media

• Study Data from Icahn School of Medicine at Mount Sinai Update Knowledge of Bladder Cancer (Induction and Maintenance of Sequential Intravesical Gemcitabine/docetaxel for Intermediate and High-risk Non-muscle Invasive Bladder Cancer With ...)

  Ranti, D., Lavallee, E., Mehrazin, R., Etienne, L., Sfakianos, J., Wiklund, P., Attalla, K. & Waingankar, N.

  10/06/24

  1 item of Media coverage

  Press/Media

• Bispecific antibody delivers positive results in relapsed, refractory multiple myeloma

  Jagannath, S.

  8/06/24

  1 item of Media coverage

  Press/Media

• The National Labor Relations Board (NLRB) Decision: Starbucks Corporation (Case Number: 08-CA-290673)

  Powell, C.

  6/06/24

  1 item of Media coverage

  Press/Media

• Research from Icahn School of Medicine at Mount Sinai in Cancer Provides New Insights [Multi-cancer early detection (MCED) tests: prioritizing equity from bench to bedside]

  Weber, E., Smith, C., Lin, J., Taioli, E., Villanueva Rodriguez, A., Sly, J. & Mazor, M.

  6/06/24

  1 item of Media coverage

  Press/Media

• Reports from Stony Brook Medicine Add New Data to Research in Gynecologic Oncology (Mitigating disparity?: Treatment patterns, survival, and recurrence rates by race, ethnicity, and hospital site across a large urban health system)

  Blank, S.

  6/06/24

  1 item of Media coverage

  Press/Media

• New Study Findings from University of California Davis School of Medicine Illuminate Research in Alzheimer Disease (The neuropathological landscape of small vessel disease and Lewy pathology in a cohort of Hispanic and non-Hispanic White ...)

  Wang, P.

  6/06/24

  1 item of Media coverage

  Press/Media

• Findings from Icahn School of Medicine at Mount Sinai Reveals New Findings on Cancer (Pan-cancer Proteogenomics Characterization of Tumor Immunity)

  Reva, B. A., Sebra, R., Wang, P., Song, X., Ma’ayan, A., Petralia, F. & Chowdhury, S.

  4/06/24

  1 item of Media coverage

  Press/Media

• Perioperative Chemo Extends Survival in Resectable Esophageal Cancer

  Goodman, K.

  3/06/24

  1 item of Media coverage

  Press/Media

• Preliminary Analysis Of Data Evaluating Investigational Epcoritamab (Duobody® Cd3xcd20) Combination Demonstrates 95% Overall Response Rate In Patients With Previously Untreated Follicular Lymphoma

  Brody, J.

  2/06/24 → 3/06/24

  15 items of Media coverage

  Press/Media

• Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma

  Brody, J.

  2/06/24 → 3/06/24

  3 items of Media coverage

  Press/Media

• MAIC Study Finds Similar Results With Linvoseltamab/Teclistamab in R/R Multiple Myeloma

  Jagannath, S.

  3/06/24

  1 item of Media coverage

  Press/Media

• MAIC Study Finds Similar Results With Linvoseltamab/Teclistamab in R/R Multiple Myeloma; Similar outcomes were noted when linvoseltamab and teclistamab were analyzed as treatments for patients with relapsed/refractory multiple myeloma.

  Jagannath, S.

  3/06/24

  1 item of Media coverage

  Press/Media

• Flamingo Therapeutics Presents Poster At ASCO 2024 On Phase II PEMDA-HN Trial For Head And Neck Squamous Cell Carcinoma (HNSCC)

  Posner, M.

  2/06/24

  158 items of Media coverage

  Press/Media

• Flamingo Therapeutics Presents Poster At ASCO 2024 On Phase II PEMDA-HN Trial For Head And Neck Squamous Cell Carcinoma (HNSCC)

  Posner, M.

  2/06/24

  1 item of Media coverage

  Press/Media

• Flamingo Therapeutics Presents Poster at ASCO 2024 on Phase II PEMDA-HN Trial for Head and Neck Squamous Cell Carcinoma (HNSCC)

  Posner, M.

  2/06/24

  1 item of Media coverage

  Press/Media

• New Cytomegalovirus Study Results from Icahn School of Medicine at Mount Sinai Described (Dynamics of Cytomegalovirus-specific T-cell Recovery In Allogeneic Hematopoietic Cell Transplant Recipients Using a Commercially Available Flow Cytometry ...)

  Govindarajulu, U., Levine, J., Keyzner, A., Jacobs, S. & Ibrahim, U.

  31/05/24

  1 item of Media coverage

  Press/Media

• Investigators at New York Genome Center Discuss Findings in Nucleoproteins (Mapping Genotypes To Chromatin Accessibility Profiles In Single Cells)

  Marcellino, B., Hoffman, R. & Izzo, F.

  30/05/24

  1 item of Media coverage

  Press/Media

• Naveris to Present New Data Highlighting Clinical Utility of the NavDx® Test at the 2024 ASCO Annual Meeting

  Misiukiewicz, K. J. & Roof, S.

  29/05/24

  4 items of Media coverage

  Press/Media

• Weekly: Regeneron (REGN: $985.02) keeps rising: up 12% in 4 weeks; +$101.82 [11.5%]

  Jagannath, S.

  28/05/24

  1 item of Media coverage

  Press/Media